Scientists develop breakthrough technology for detecting protein modifications

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

Janssen looks to turn PhIII win for Rybrevant in EGFR-mutated NSCLC into pressure on AstraZeneca blockbuster

Johnson & Johnson’s Janssen said Wednesday that its bispecific antibody Rybrevant (amivantamab-vmjw) in combo with lazertinib met its dual primary endpoints in a Phase III

September 7, 2023

Potentially Protective Agent Shows Benefit in Niemann-Pick Type C

Patients with Niemann-Pick disease type C who received N-acetyl-L-leucine (NALL), an agent that potentially ameliorates lysosomal and metabolic dysfunction, showed reduced neurologic signs and symptoms

February 1, 2024

Axial Spondyloarthritis: Treatment Update

For patients with axial spondyloarthritis (axSpA) who do not benefit from or cannot take nonsteroidal anti-inflammatory drugs (NSAIDs), new treatment options include agents in multiple

November 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.